Further analysis focusing on CD25+bright (top 10%) and CD25+very bright (top 2%) cells revealed a similar expression of the markers FoxP3 and CD127 among all individuals, both on the levels of percentage positive cells (Figure 1c, d), as well on the mean fluorescence intensity (MFI, data not shown).
They also had lower levels of percentage mammographic density, and higher serum and urinary MDA levels.
A number of baseline variables were associated with serially measured levels of percentage predicted FVC.
eFive levels of interest (from 1 (no special interest) to 5 (very much interest)) and 5 levels of percentage of patients treated by the GP (0%-100 0%-100
Compared with Caucasians, premenopausal and postmenopausal East Asian women and premenopausal Jewish women were lighter, with lower mean BMIs and greater levels of percentage breast density.
In our study, African American patients had lower levels of percentage predicted FVC, even after adjusting for socioeconomic factors, antibody status and smoking habits.
MHO women demonstrated significantly higher levels of percentage of leg fat and significantly lower levels of waist circumference, despite no significant differences in overall adiposity, as measured by BMI, FMI, and percentage of total fat, compared with MRO women.
Postmenopausal women had higher average BMI and WHR, and lower circulating levels of estradiol, SHBG and IGF-1, lower levels of percentage mammographic density, and higher levels of free estradiol, IGFBP-3, and total plasma cholesterol and triglycerides.
Our levels of percentage agreement were similar to those between clinician and cancer patient self-ratings when assessing symptoms[ 31], where the levels of disagreement did not affect treatment decisions.
